The CSRP3 gene helps heart and skeletal muscle cells keep their shape and handle stretch during each heartbeat and movement. This gene plays an important role in keeping muscle fibers organized and working smoothly. Pathogenic variants in the CSRP3 gene can cause inherited cardiomyopathy, meaning the heart muscle may become unusually thick or less able to pump well. People carrying one of these variants may develop symptoms such as shortness of breath, tiredness, palpitations, or fainting, although timing and severity can vary.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for building proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more information in the LearnHub.
Overview
CSRP3Gene function
What if the gene works
The CSRP3 gene helps heart and skeletal muscle cells keep their internal support structure organized and respond to stretch. This supports steady muscle function, especially in the heart.
Risk
What if the gene does not work
Pathogenic variants in the CSRP3 gene can cause inherited heart muscle disease, most often hypertrophic cardiomyopathy and sometimes dilated cardiomyopathy. Milder or severe variants may influence when changes appear and how much they affect heart thickening, stretching, rhythm, and pumping.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the CSRP3 gene does not currently point to a CSRP3-specific medicine or management plan. Treatment and drug choices usually follow standard care for the person’s heart condition, rather than the CSRP3 variant itself.
Conditions associated with CSRP3
Gene function
What if the gene works
The CSRP3 gene is active mainly in heart and skeletal muscle, where cells need to stretch, contract, and recover with every beat or movement. Its protein helps keep the inner support system of muscle cells organized and helps those cells respond to physical strain. Understanding what the CSRP3 gene does in heart muscle can make genetic results easier to place in context.
The CSRP3 protein sits in key support areas inside muscle cells and helps keep their contractile parts lined up. This steady layout supports smooth, coordinated shortening and relaxation in heart and skeletal muscle.
Muscle cells are stretched and pulled with each heartbeat and movement. CSRP3 helps them sense that load and pass along signals so the cell can adjust to everyday mechanical stress.
Some CSRP3 protein can enter the nucleus (the cell's control center) and help regulate genes involved in muscle work. This supports the normal development and upkeep of working muscle cells.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not produce any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants in the CSRP3 gene affect protein function starts with the protein they alter in heart muscle cells. Some variants change the protein's shape, make it less stable, or weaken its links within the sarcomere (the muscle cell structure that helps cells contract), while more disruptive variants can greatly reduce or stop protein activity. Milder variants may partly preserve function, whereas more severe variants often have a stronger effect and can be linked to earlier or more pronounced cardiomyopathy.
How variants are linked to conditions
Pathogenic variants in the CSRP3 gene can cause inherited cardiomyopathy, most often hypertrophic cardiomyopathy and less often dilated cardiomyopathy. In families with a CSRP3 gene variant linked to hypertrophic cardiomyopathy, the heart muscle may become abnormally thick. Some variants in the same gene are also associated with a stretched, weaker heart muscle seen in dilated cardiomyopathy. Not every CSRP3 gene change is disease-causing, so the exact variant matters.
A variant is not necessarily a diagnosis
Variants are a routine feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant connected with a condition suggests a possible association rather than a definite diagnosis, particularly when multiple genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CSRP3, risk is mainly tied to whether someone carries a disease-causing gene change, and family history can matter too. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or lower CSRP3-related risk, so people with concerns about their personal risk should speak with a doctor or genetic counselor.
Inheritance of CSRP3 variants
CSRP3-related conditions are usually inherited in an autosomal dominant pattern. This means a person carrying a disease-causing variant in the CSRP3 gene has one changed copy and one usual copy, and each child has a 50% chance of inheriting that variant. In practical terms, CSRP3 gene variant inheritance often shows up across generations, with an affected parent passing it to a son or daughter. Men and women can inherit and pass on CSRP3 variants equally.
What does my CSRP3 result mean for my family?
For many CSRP3 results linked to inherited heart muscle conditions, the pattern is usually dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. In practical terms, each child of someone with a disease-causing CSRP3 variant has a 1 in 2 chance of inheriting it. Because of that, family members may also want to learn whether the variant is present in them.
Genetic information
Genetic testing
How you find out about variants
CSRP3 genetic testing uses a blood sample, saliva sample, or cheek swab to read the CSRP3 gene and look for variants linked to inherited heart muscle conditions. Results may show a disease causing variant, a harmless variant, or a variant whose meaning is still unclear.
When should I consider getting a genetic test?
Consider genetic testing for CSRP3 if you or close relatives have an inherited heart muscle condition, especially a thickened or weakened heart muscle that started at a young age or runs in the family. It can help clarify whether CSRP3 is part of the cause and whether relatives may also need testing.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one of several factors, along with age, liver and kidney function, and other medicines, that can influence treatment response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to better understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CSRP3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. Questions about side effects, how well a treatment is working, or any new health concerns are best discussed with your doctor or pharmacist.
History
The CSRP3 gene entered medical genetics through research on inherited heart muscle conditions in the late 1990s and early 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, CSRP3 became linked to families with hypertrophic cardiomyopathy, a condition in which the heart muscle becomes abnormally thick. Researchers then identified CSRP3 variants in some people with dilated cardiomyopathy, which broadened its clinical importance. From these first observations, research expanded steadily. Over time, scientists learned that different CSRP3 variants could be associated with different patterns of heart disease, helping refine genetic testing and family studies. This work placed the CSRP3 gene among the established genes involved in inherited cardiomyopathy.